Opinion: Precision medicine has a blind spot: children with cancer
We must do more to help patients and families across the arc of their cancer experiences, from coping with cancer diagnoses to breaking down barriers to care and living with…
Cancer, once a terrifying black box, is slowly being opened up. Thanks to advances in technology and genomics, we know significantly more today about what drives cancer.
Precision medicine, the concept of giving the right treatment to the right patient at the right time, is flourishing in cancer treatment. But there is a blind spot: children are not benefiting enough from the progress we’re making.
We need a full-scale renaissance in pediatric drug development and care. And we need it now.
Researchers and clinicians have been chipping away at the devastating threats from in children — and many other cancers. This same strategy, high-dose combination chemotherapy, is still used to treat ALL.
